In Publications

Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (action within 48 hours): Chatfield Pharmaceuticals Ltd - Atenolol 25, 50 & 100mg Tablets - EL(07)A/19

Printer friendly version (new window)

Document details:

Type: Drug Alert
Series No: EL(07)A/19
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 1
Price: free
ISBN/ISSN:
Author:
Copyright: Crown
   

DRUG ALERT

Class 2 medicines recall
Action within 48 hours
Pharmacy (or equivalent) level recall
01 November 2007 EL(07)A/19 Our ref:  MDR 25-10/07

Dear Healthcare Professional,

Chatfield Pharmaceuticals

Atenolol

Chatfield Pharmaceuticals Ltd
Atenolol 25, 50 & 100mg Tablets

PL 2142/0038
PL 2142/0039
PL 2142/0040


Chatfield Pharmaceuticals Ltd are recalling any remaining stock of the above products due to multiple GMP failures at their contract manufacturer. We understand this stock has only been supplied in packs of 28 tablets.

Recipients are requested to quarantine any remaining stock and return it to their supplier for credit.

For further information please telephone Dr David Solomon 020 7835 5990.

Recipients of this Drug Alert should bring this information to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to bring this information to the attention of relevant clinics, General Practitioners and Community Pharmacists by copy of this letter.

Yours faithfully,

Ian Holloway

DMRC Manager

MHRA Distribution (further recipients by cascade):
Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Medical Supplies Agency (MOD)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Page last modified: 01 November 2007